vs

Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.

AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $132.7M, roughly 1.4× Emerald Holding, Inc.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -22.8%, a 23.7% gap on every dollar of revenue. On growth, Emerald Holding, Inc. posted the faster year-over-year revenue change (24.3% vs 23.7%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $11.7M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -0.3%).

TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

EEX vs FOLD — Head-to-Head

Bigger by revenue
FOLD
FOLD
1.4× larger
FOLD
$185.2M
$132.7M
EEX
Growing faster (revenue YoY)
EEX
EEX
+0.5% gap
EEX
24.3%
23.7%
FOLD
Higher net margin
FOLD
FOLD
23.7% more per $
FOLD
0.9%
-22.8%
EEX
More free cash flow
FOLD
FOLD
$4.3M more FCF
FOLD
$16.0M
$11.7M
EEX
Faster 2-yr revenue CAGR
FOLD
FOLD
Annualised
FOLD
29.5%
-0.3%
EEX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EEX
EEX
FOLD
FOLD
Revenue
$132.7M
$185.2M
Net Profit
$-30.2M
$1.7M
Gross Margin
85.7%
Operating Margin
-11.8%
8.6%
Net Margin
-22.8%
0.9%
Revenue YoY
24.3%
23.7%
Net Profit YoY
-692.2%
-88.5%
EPS (diluted)
$-0.15
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EEX
EEX
FOLD
FOLD
Q4 25
$132.7M
$185.2M
Q3 25
$77.5M
$169.1M
Q2 25
$105.5M
$154.7M
Q1 25
$147.7M
$125.2M
Q4 24
$106.8M
$149.7M
Q3 24
$72.6M
$141.5M
Q2 24
$86.0M
$126.7M
Q1 24
$133.4M
$110.4M
Net Profit
EEX
EEX
FOLD
FOLD
Q4 25
$-30.2M
$1.7M
Q3 25
$-14.4M
$17.3M
Q2 25
$-1.4M
$-24.4M
Q1 25
$15.3M
$-21.7M
Q4 24
$5.1M
$14.7M
Q3 24
$-11.1M
$-6.7M
Q2 24
$-2.8M
$-15.7M
Q1 24
$11.0M
$-48.4M
Gross Margin
EEX
EEX
FOLD
FOLD
Q4 25
85.7%
Q3 25
88.5%
Q2 25
90.2%
Q1 25
90.7%
Q4 24
90.1%
Q3 24
90.6%
Q2 24
91.1%
Q1 24
87.7%
Operating Margin
EEX
EEX
FOLD
FOLD
Q4 25
-11.8%
8.6%
Q3 25
-10.1%
20.3%
Q2 25
9.7%
-6.1%
Q1 25
24.2%
-6.3%
Q4 24
19.5%
10.7%
Q3 24
-6.5%
15.3%
Q2 24
7.4%
11.8%
Q1 24
18.2%
-25.1%
Net Margin
EEX
EEX
FOLD
FOLD
Q4 25
-22.8%
0.9%
Q3 25
-18.6%
10.2%
Q2 25
-1.3%
-15.8%
Q1 25
10.4%
-17.3%
Q4 24
4.8%
9.8%
Q3 24
-15.3%
-4.8%
Q2 24
-3.3%
-12.4%
Q1 24
8.2%
-43.9%
EPS (diluted)
EEX
EEX
FOLD
FOLD
Q4 25
$-0.15
$0.00
Q3 25
$-0.07
$0.06
Q2 25
$-0.01
$-0.08
Q1 25
$0.08
$-0.07
Q4 24
$0.01
$0.05
Q3 24
$-0.05
$-0.02
Q2 24
$-0.03
$-0.05
Q1 24
$0.00
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EEX
EEX
FOLD
FOLD
Cash + ST InvestmentsLiquidity on hand
$100.9M
$293.5M
Total DebtLower is stronger
$392.7M
Stockholders' EquityBook value
$338.8M
$274.2M
Total Assets
$1.2B
$949.9M
Debt / EquityLower = less leverage
1.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EEX
EEX
FOLD
FOLD
Q4 25
$100.9M
$293.5M
Q3 25
$95.4M
$263.8M
Q2 25
$156.4M
$231.0M
Q1 25
$276.8M
$250.6M
Q4 24
$194.8M
$249.9M
Q3 24
$188.9M
$249.8M
Q2 24
$193.2M
$260.1M
Q1 24
$186.8M
$239.6M
Total Debt
EEX
EEX
FOLD
FOLD
Q4 25
$392.7M
Q3 25
$392.0M
Q2 25
$391.3M
Q1 25
$390.7M
Q4 24
$390.1M
Q3 24
$389.5M
Q2 24
$388.9M
Q1 24
$388.4M
Stockholders' Equity
EEX
EEX
FOLD
FOLD
Q4 25
$338.8M
$274.2M
Q3 25
$369.5M
$230.4M
Q2 25
$389.4M
$204.3M
Q1 25
$392.1M
$193.6M
Q4 24
$385.9M
$194.0M
Q3 24
$391.1M
$178.8M
Q2 24
$407.6M
$132.5M
Q1 24
$-90.7M
$130.7M
Total Assets
EEX
EEX
FOLD
FOLD
Q4 25
$1.2B
$949.9M
Q3 25
$1.2B
$868.8M
Q2 25
$1.2B
$815.3M
Q1 25
$1.2B
$789.8M
Q4 24
$1.0B
$785.0M
Q3 24
$1.1B
$786.6M
Q2 24
$1.1B
$749.5M
Q1 24
$1.1B
$721.8M
Debt / Equity
EEX
EEX
FOLD
FOLD
Q4 25
1.43×
Q3 25
1.70×
Q2 25
1.92×
Q1 25
2.02×
Q4 24
2.01×
Q3 24
2.18×
Q2 24
2.93×
Q1 24
2.97×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EEX
EEX
FOLD
FOLD
Operating Cash FlowLast quarter
$12.3M
$16.3M
Free Cash FlowOCF − Capex
$11.7M
$16.0M
FCF MarginFCF / Revenue
8.8%
8.6%
Capex IntensityCapex / Revenue
0.5%
0.2%
Cash ConversionOCF / Net Profit
9.62×
TTM Free Cash FlowTrailing 4 quarters
$41.4M
$29.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EEX
EEX
FOLD
FOLD
Q4 25
$12.3M
$16.3M
Q3 25
$1.8M
$35.7M
Q2 25
$15.9M
$-26.5M
Q1 25
$12.6M
$7.8M
Q4 24
$20.6M
$-3.9M
Q3 24
$9.1M
$-23.0M
Q2 24
$9.8M
$22.7M
Q1 24
$7.3M
$-29.7M
Free Cash Flow
EEX
EEX
FOLD
FOLD
Q4 25
$11.7M
$16.0M
Q3 25
$1.5M
$35.3M
Q2 25
$15.8M
$-28.9M
Q1 25
$12.4M
$7.5M
Q4 24
$19.9M
$-4.2M
Q3 24
$9.0M
$-23.3M
Q2 24
$9.6M
$21.6M
Q1 24
$7.0M
$-31.5M
FCF Margin
EEX
EEX
FOLD
FOLD
Q4 25
8.8%
8.6%
Q3 25
1.9%
20.9%
Q2 25
15.0%
-18.7%
Q1 25
8.4%
6.0%
Q4 24
18.6%
-2.8%
Q3 24
12.4%
-16.5%
Q2 24
11.2%
17.0%
Q1 24
5.2%
-28.5%
Capex Intensity
EEX
EEX
FOLD
FOLD
Q4 25
0.5%
0.2%
Q3 25
0.4%
0.2%
Q2 25
0.1%
1.6%
Q1 25
0.1%
0.2%
Q4 24
0.7%
0.2%
Q3 24
0.1%
0.3%
Q2 24
0.2%
0.9%
Q1 24
0.2%
1.6%
Cash Conversion
EEX
EEX
FOLD
FOLD
Q4 25
9.62×
Q3 25
2.06×
Q2 25
Q1 25
0.82×
Q4 24
4.04×
-0.27×
Q3 24
Q2 24
Q1 24
0.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EEX
EEX

Connections Segment$121.9M92%
Commerce Segment$5.5M4%
Content$5.3M4%

FOLD
FOLD

Other$105.8M57%
Galafold$64.8M35%
Pombiliti Opfolda$14.6M8%

Related Comparisons